Cargando…
A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue
The diagnostics of Lynch syndrome (LS) is focused on the detection of DNA mismatch repair (MMR) system deficiency. MMR deficiency can be detected on tumor tissue by microsatellite instability (MSI) using molecular genetic test or by loss of expression of one of the four proteins (MLH1, MSH2, MSH6, a...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140785/ https://www.ncbi.nlm.nih.gov/pubmed/32197529 http://dx.doi.org/10.3390/genes11030325 |
_version_ | 1783519068205088768 |
---|---|
author | Klančar, Gašper Blatnik, Ana Šetrajčič Dragoš, Vita Vogrič, Vesna Stegel, Vida Blatnik, Olga Drev, Primož Gazič, Barbara Krajc, Mateja Novaković, Srdjan |
author_facet | Klančar, Gašper Blatnik, Ana Šetrajčič Dragoš, Vita Vogrič, Vesna Stegel, Vida Blatnik, Olga Drev, Primož Gazič, Barbara Krajc, Mateja Novaković, Srdjan |
author_sort | Klančar, Gašper |
collection | PubMed |
description | The diagnostics of Lynch syndrome (LS) is focused on the detection of DNA mismatch repair (MMR) system deficiency. MMR deficiency can be detected on tumor tissue by microsatellite instability (MSI) using molecular genetic test or by loss of expression of one of the four proteins (MLH1, MSH2, MSH6, and PMS2) involved in the MMR system using immunohistochemistry (IHC) staining. According to the National Comprehensive Cancer Network (NCCN) guidelines, definitive diagnosis of LS requires the identification of the germline pathogenic variant in one of the MMR genes. In the report, we are presenting interesting novel MLH1 in-frame deletion LRG_216t1:c.2236_2247delCTGCCTGATCTA p.(Leu746_Leu749del) associated with LS. The variant appears to be associated with uncommon isolated loss of PMS2 immunohistochemistry protein staining (expression) in tumor tissue instead of MLH1 and PMS2 protein loss, which is commonly seen with pathogenic variants in MLH1. The variant was classified as likely pathogenic, based on segregation analysis and molecular characterization of blood and tumor samples. According to the American College of Medical Genetics (ACMG) guidelines, the following evidence categories of PM1, PM2, PM4, and PP1 moderate have been used for classification of the novel variant. By detecting and classifying the novel MLH1 variant as likely pathogenic, we confirmed the LS in this family. |
format | Online Article Text |
id | pubmed-7140785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71407852020-04-13 A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue Klančar, Gašper Blatnik, Ana Šetrajčič Dragoš, Vita Vogrič, Vesna Stegel, Vida Blatnik, Olga Drev, Primož Gazič, Barbara Krajc, Mateja Novaković, Srdjan Genes (Basel) Article The diagnostics of Lynch syndrome (LS) is focused on the detection of DNA mismatch repair (MMR) system deficiency. MMR deficiency can be detected on tumor tissue by microsatellite instability (MSI) using molecular genetic test or by loss of expression of one of the four proteins (MLH1, MSH2, MSH6, and PMS2) involved in the MMR system using immunohistochemistry (IHC) staining. According to the National Comprehensive Cancer Network (NCCN) guidelines, definitive diagnosis of LS requires the identification of the germline pathogenic variant in one of the MMR genes. In the report, we are presenting interesting novel MLH1 in-frame deletion LRG_216t1:c.2236_2247delCTGCCTGATCTA p.(Leu746_Leu749del) associated with LS. The variant appears to be associated with uncommon isolated loss of PMS2 immunohistochemistry protein staining (expression) in tumor tissue instead of MLH1 and PMS2 protein loss, which is commonly seen with pathogenic variants in MLH1. The variant was classified as likely pathogenic, based on segregation analysis and molecular characterization of blood and tumor samples. According to the American College of Medical Genetics (ACMG) guidelines, the following evidence categories of PM1, PM2, PM4, and PP1 moderate have been used for classification of the novel variant. By detecting and classifying the novel MLH1 variant as likely pathogenic, we confirmed the LS in this family. MDPI 2020-03-18 /pmc/articles/PMC7140785/ /pubmed/32197529 http://dx.doi.org/10.3390/genes11030325 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Klančar, Gašper Blatnik, Ana Šetrajčič Dragoš, Vita Vogrič, Vesna Stegel, Vida Blatnik, Olga Drev, Primož Gazič, Barbara Krajc, Mateja Novaković, Srdjan A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue |
title | A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue |
title_full | A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue |
title_fullStr | A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue |
title_full_unstemmed | A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue |
title_short | A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue |
title_sort | novel germline mlh1 in-frame deletion in a slovenian lynch syndrome family associated with uncommon isolated pms2 loss in tumor tissue |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140785/ https://www.ncbi.nlm.nih.gov/pubmed/32197529 http://dx.doi.org/10.3390/genes11030325 |
work_keys_str_mv | AT klancargasper anovelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT blatnikana anovelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT setrajcicdragosvita anovelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT vogricvesna anovelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT stegelvida anovelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT blatnikolga anovelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT drevprimoz anovelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT gazicbarbara anovelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT krajcmateja anovelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT novakovicsrdjan anovelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT klancargasper novelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT blatnikana novelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT setrajcicdragosvita novelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT vogricvesna novelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT stegelvida novelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT blatnikolga novelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT drevprimoz novelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT gazicbarbara novelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT krajcmateja novelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue AT novakovicsrdjan novelgermlinemlh1inframedeletioninaslovenianlynchsyndromefamilyassociatedwithuncommonisolatedpms2lossintumortissue |